Abstract: In a method for advanced identification of a customer, a customer may remotely place an order, intending to later go to a store to pick up the ordered item. The store may have a pick-up area (e.g., at the back of the store) where the customer can go to pick up the ordered item. To save the customer time, the customer may be identified when she enters the store so that an employee can obtain her ordered item and have it ready to pick up by the time the customer walks through the store and arrives at the pick-up area.

Abstract: There is described a medical device for management of the axial length growth of an eye of a subject. The device comprises a central region having a first power, a transition region surrounding the central region, and a peripheral region surrounding the transition region and having a second power. The transition region has a width at most equal to 1.5 mm. The second power is chosen based on the first power to achieve a target net power, the target net power being the addition of the first power and the second power. The surface area of the central and peripheral regions is chosen as a function of the surface area of the pupil of the eye. Furthermore, the curve of power within the transition region is steep between the first power and the second power so that the transition region generates no optically usable power.

Abstract: A medical device for management of an axial length growth of an eye of a subject, the eye having a pupil, the device comprising: a central region having a first power; a transition region surrounding the central region and having a width at most equal to 1.5 mm; and a peripheral region surrounding the transition region, the peripheral region having a second power, wherein a surface area of each one of the central and peripheral regions is chosen as a function of a surface area of the pupil of the eye.

Abstract: The invention relates to the use of a medicinal kit comprising N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide for helping to quit tobacco consumption.

Abstract: This invention relates to a therapeutic composition comprising, as active ingredient, a combination of a pyridine derivative having an anti-blood-platelet-aggregation activity and of sulfinpyrazone.Said composition has outstanding anti-blood-platelet-aggregating and antithrombotic properties, both components of the active ingredient functioning according to a synergistic effect.

Abstract: This invention relates to a therapeutic composition comprising, as active ingredient, a combination of a pyridine derivative having an anti-blood-platelet-aggregation activity and of sulfinpyrazone.Said composition has outstanding anti-blood-platelet-aggregating and antithrombotic properties, both components of the active ingredient functioning according to a synergistic effect.

Abstract: This invention relates to therapeutic compositions comprising, as active ingredients, a combination of a pyridine derivative having an anti-blood-platelet-aggregation activity with a derivative having beta-blocking properties, which exhibit synergistic anti-thrombotic activity.

Abstract: This invention relates to a process for the treatment of patients suffering from drepanocytosis, comprising administering to said patients a therapeutically effective dosage of a pyridine derivative having the formula: ##STR1## in which X is oxygen or sulfur; R is oxygen or a phenyl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, nitro, amino, sulfonylamino, aryl, carboxy, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; styryl, naphthyl, thienyl or benzhydryl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, aryl, nitro, amino, sulfonylamino, carboxyl, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; benzoyl optionally substituted with at least a halogen, lower alkyl, lower alkoxy, nitro, amino or sulfonylamino group; R.sub.1 and R.sub.2 each represent at least one atom or group selected from hydrogen, halogen, hydroxy, lower alkyl, lower alkoxy, nitro or amino; R.sub.

Abstract: The invention provides matching circuitry for use with a radar station and television magnetoscope, the latter having a video channel and an audio channel. The matching circuitry enables the audio channel of the magnetoscope to be used for information concerning the instantaneous position of the antenna of the radar station, and the video channel for video and synchronizing signals. An oscillator isused to supply artificial frame pulses to a control track of the video channel of the magnetoscope. The recordings of these pulses are used to synchronize the video reading head of the magnetoscope when the information is being retrieved or reproduced from the magnetoscope.

Abstract: This invention relates to a process for the treatment of patients suffering from drepanocytosis, comprising administering to said patients a therapeutically effective dosage of a pyridine derivative having the formula: ##STR1## in which X is oxygen or sulfur; R is oxygen or a phenyl radical optionally substituted with at least a halogen atom or a lower alkyl, lower alkoxy, nitro, amino, sufonylamino, aryl, carboxy, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; a styryl, naphthyl, thienyl or benzhydryl radical optionally substituted with at least a halogen atom or a lower alkyl, lower alkoxy, aryl, nitro, amino, sulfonylamino, carboxy, alkoxycarbonyl, cyano, hydroxymethyl or methylenedioxy group; or a benzoyl radical optionally substituted with at least a halogen atom or a lower alkyl, lower alkoxy, nitro, amino or sulfonylamino group; R.sub.1 and R.sub.2 represent each at least an atom or group selected from hydrogen, halogen, or a hydroxy, lower alkyl, lower alkoxy, nitro or amino group; R.